1. The analysis of secondary AA-amyloidosis current etiology and its influence on the approaches for diagnosis and treatment
- Author
-
Vilen V. Rameev, Lidiia V. Kozlovskaya, Anna S. Rameeva, Aleksandr V. Novikov, and Mariia V. Barsuk
- Subjects
aa-amyloidosis ,saa ,rheumatoid arthritis ,autoinflammatory diseases ,mediterranean fever ,castleman's disease ,s100a12 ,Medicine - Abstract
Aim. To investigate an influence of the currently changed etiologic structure of AA-amyloidosis on the diagnosis and treatment tactics. Materials and methods. In 110 patients with АА-amyloidosis followed during full disease duration (1 month 29 years) etiology, clinical manyfestations and approaches to diagnose and treatment of AA-amyloidosis were evaluated. With ELISA levels of amyloid precursor acute phase inflammation reactant SAA and neutrophil activity marker S100A12 were measured. Results. Among the most common causes of AA-amyloidosis at the present stage, in addition to RA (40.3%), a significant place is occupied by a group of diseases with a predominantly autoinflammatory mechanism (53.73%). To confirm the autoinflammatory mechanism of the predisposing disease it is recommended to study a highly sensitive parameter serum protein S100A12. An effective marker of the risk of AA-amyloidosis progression, especially in patients with subclinical activity of inflammatory disease, is a high level of production of amyloidogenic protein-a precursor of SAA.
- Published
- 2021
- Full Text
- View/download PDF